Extendicare Inc. (TSX: EXE.TO) Stock Competitors & Peer Comparison
See EXE.TO's competitors and their performance on the TSX and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EXE.TO and its TSX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EXE.TO | CA$31.70 | +3.06% | 3B | 23.27 | CA$1.36 | +1.62% |
| SIA.TO | CA$21.47 | -0.51% | 2.1B | 41.29 | CA$0.52 | +4.35% |
| DNTL.TO | CA$11.00 | +0.09% | 2.1B | -78.57 | -CA$0.14 | +0.23% |
| WELL.TO | CA$4.34 | +0.70% | 1.1B | 9.29 | CA$0.47 | N/A |
| DR.TO | CA$15.60 | +0.32% | 273.8M | 16.51 | CA$0.94 | +2.31% |
| AIDX.TO | CA$0.76 | +0.00% | 230M | -4.39 | -CA$0.17 | N/A |
| CRRX.TO | CA$3.24 | +0.00% | 205.6M | 7.67 | CA$0.42 | +2.47% |
| DRDR.TO | CA$0.55 | -9.84% | 49.4M | -0.83 | -CA$0.66 | N/A |
| GTMS.TO | CA$0.97 | -15.65% | 28.6M | -0.45 | -CA$2.14 | N/A |
| NUMI.TO | CA$0.05 | +0.00% | 16M | -0.63 | -CA$0.08 | N/A |
Stock Comparison
Sienna Senior Living Inc. (TSX: SIA.TO)
EXE.TO vs SIA.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, SIA.TO has a market cap of 2.1B. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while SIA.TO trades at CA$21.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas SIA.TO's P/E ratio is 41.29. In terms of profitability, EXE.TO's ROE is +0.36%, compared to SIA.TO's ROE of +0.07%. Regarding short-term risk, EXE.TO is more volatile compared to SIA.TO. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check SIA.TO's competition here
dentalcorp Holdings Ltd. (TSX: DNTL.TO)
EXE.TO vs DNTL.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, DNTL.TO has a market cap of 2.1B. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while DNTL.TO trades at CA$11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas DNTL.TO's P/E ratio is -78.57. In terms of profitability, EXE.TO's ROE is +0.36%, compared to DNTL.TO's ROE of -0.01%. Regarding short-term risk, EXE.TO is more volatile compared to DNTL.TO. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check DNTL.TO's competition here
WELL Health Technologies Corp. (TSX: WELL.TO)
EXE.TO vs WELL.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, WELL.TO has a market cap of 1.1B. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while WELL.TO trades at CA$4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas WELL.TO's P/E ratio is 9.29. In terms of profitability, EXE.TO's ROE is +0.36%, compared to WELL.TO's ROE of +0.00%. Regarding short-term risk, EXE.TO is more volatile compared to WELL.TO. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check WELL.TO's competition here
Medical Facilities Corporation (TSX: DR.TO)
EXE.TO vs DR.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, DR.TO has a market cap of 273.8M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while DR.TO trades at CA$15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas DR.TO's P/E ratio is 16.51. In terms of profitability, EXE.TO's ROE is +0.36%, compared to DR.TO's ROE of +0.45%. Regarding short-term risk, EXE.TO is more volatile compared to DR.TO. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check DR.TO's competition here
Healwell AI Inc. (TSX: AIDX.TO)
EXE.TO vs AIDX.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, AIDX.TO has a market cap of 230M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while AIDX.TO trades at CA$0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas AIDX.TO's P/E ratio is -4.39. In terms of profitability, EXE.TO's ROE is +0.36%, compared to AIDX.TO's ROE of -0.24%. Regarding short-term risk, EXE.TO is more volatile compared to AIDX.TO. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check AIDX.TO's competition here
CareRx Corporation (TSX: CRRX.TO)
EXE.TO vs CRRX.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, CRRX.TO has a market cap of 205.6M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while CRRX.TO trades at CA$3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas CRRX.TO's P/E ratio is 7.67. In terms of profitability, EXE.TO's ROE is +0.36%, compared to CRRX.TO's ROE of +0.26%. Regarding short-term risk, EXE.TO is more volatile compared to CRRX.TO. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check CRRX.TO's competition here
MCI Onehealth Technologies Inc. (TSX: DRDR.TO)
EXE.TO vs DRDR.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, DRDR.TO has a market cap of 49.4M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while DRDR.TO trades at CA$0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas DRDR.TO's P/E ratio is -0.83. In terms of profitability, EXE.TO's ROE is +0.36%, compared to DRDR.TO's ROE of -1.02%. Regarding short-term risk, EXE.TO is less volatile compared to DRDR.TO. This indicates lower risk in terms of short-term price fluctuations for EXE.TO.Check DRDR.TO's competition here
Greenbrook TMS Inc. (TSX: GTMS.TO)
EXE.TO vs GTMS.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, GTMS.TO has a market cap of 28.6M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while GTMS.TO trades at CA$0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas GTMS.TO's P/E ratio is -0.45. In terms of profitability, EXE.TO's ROE is +0.36%, compared to GTMS.TO's ROE of +15.74%. Regarding short-term risk, EXE.TO is less volatile compared to GTMS.TO. This indicates lower risk in terms of short-term price fluctuations for EXE.TO.Check GTMS.TO's competition here
Numinus Wellness Inc. (TSX: NUMI.TO)
EXE.TO vs NUMI.TO Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, NUMI.TO has a market cap of 16M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while NUMI.TO trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas NUMI.TO's P/E ratio is -0.63. In terms of profitability, EXE.TO's ROE is +0.36%, compared to NUMI.TO's ROE of +8.33%. Regarding short-term risk, EXE.TO is more volatile compared to NUMI.TO. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check NUMI.TO's competition here
Empower Clinics Inc. (CNQ: EPW.CN)
EXE.TO vs EPW.CN Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, EPW.CN has a market cap of 3.6M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while EPW.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas EPW.CN's P/E ratio is -0.77. In terms of profitability, EXE.TO's ROE is +0.36%, compared to EPW.CN's ROE of +0.47%. Regarding short-term risk, EXE.TO is more volatile compared to EPW.CN. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check EPW.CN's competition here
TripSitter Clinic Ltd. (CNQ: KETA.CN)
EXE.TO vs KETA.CN Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, KETA.CN has a market cap of 3.3M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while KETA.CN trades at CA$0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas KETA.CN's P/E ratio is -5.18. In terms of profitability, EXE.TO's ROE is +0.36%, compared to KETA.CN's ROE of +0.08%. Regarding short-term risk, EXE.TO is more volatile compared to KETA.CN. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check KETA.CN's competition here
Revitalist Lifestyle and Wellness Ltd. (CNQ: CALM.CN)
EXE.TO vs CALM.CN Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, CALM.CN has a market cap of 2.8M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while CALM.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas CALM.CN's P/E ratio is -0.12. In terms of profitability, EXE.TO's ROE is +0.36%, compared to CALM.CN's ROE of +3.14%. Regarding short-term risk, EXE.TO is more volatile compared to CALM.CN. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check CALM.CN's competition here
Optima Medical Innovations Corp. (CNQ: OMIC.CN)
EXE.TO vs OMIC.CN Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, OMIC.CN has a market cap of 2.3M. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while OMIC.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas OMIC.CN's P/E ratio is -4.50. In terms of profitability, EXE.TO's ROE is +0.36%, compared to OMIC.CN's ROE of -0.83%. Regarding short-term risk, EXE.TO is more volatile compared to OMIC.CN. This indicates higher risk in terms of short-term price fluctuations for EXE.TO.Check OMIC.CN's competition here
Wellbeing Digital Sciences Inc. (NEO: MEDI.NE)
EXE.TO vs MEDI.NE Comparison August 2026
Extendicare Inc. (TSX: EXE.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EXE.TO stands at 3B. In comparison, MEDI.NE has a market cap of 17.8K. Regarding current trading prices, EXE.TO is priced at CA$31.70 on the TSX, while MEDI.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EXE.TO currently has a P/E ratio of 23.27, whereas MEDI.NE's P/E ratio is -0.02. In terms of profitability, EXE.TO's ROE is +0.36%, compared to MEDI.NE's ROE of N/A. Regarding short-term risk, EXE.TO is less volatile compared to MEDI.NE. This indicates lower risk in terms of short-term price fluctuations for EXE.TO.Check MEDI.NE's competition here